The QT interval on an electrocardiogram (ECG) represents the time it takes for the heart's ventricles to depolarize and then fully repolarize, or reset, in preparation for the next beat. A prolonged QT interval is a significant finding because it disrupts this delicate electrical cycle, creating a vulnerable window during which the heart is prone to dangerous arrhythmias. Understanding what causes prolonged QT interval is essential for clinicians and patients alike, as it allows for targeted intervention and prevention of potentially life-threatening events.
Primary Genetic Causes of Prolongation
For a subset of individuals, the root of the problem is congenital, stemming from inherited mutations in genes responsible for cardiac ion channels. These genetic conditions, collectively known as Long QT Syndrome (LQTS), result in a baseline abnormality of repolarization that is often present from birth or discovered later in life. The mutations typically affect potassium or sodium channels, altering the flow of ions that dictate the duration of the action potential.
Common Genetic Variants
LQT1, often triggered by emotional stress or exercise, is the most common form and is linked to mutations in the KCNQ1 gene.
LQT2, frequently associated with auditory triggers like alarm sounds, involves mutations in the HERG (KCNH2) gene.
LQT3, characterized by events during sleep, involves mutations in the SCN5A gene, which affects sodium channel function.
Because these conditions are genetic, they require specific management strategies, including beta-blockers and lifestyle modifications, to mitigate the risk of sudden cardiac death.
Acquired Causes: Medications and Substances
A far more common cause of prolonged QT interval in the general population is the acquisition of the condition through external factors, primarily medications. The heart's ion channels are sensitive to a wide array of drugs, and unintended off-target effects can inadvertently block the rapid delayed rectifier potassium current (Ikr), leading to delayed repolarization.
High-Risk Pharmacological Categories
Certain antibiotics, such as fluoroquinolones (e.g., levofloxacin) and macrolides (e.g., azithromycin), are well-documented triggers.
Antiarrhythmic drugs used to treat other heart rhythm problems, like amiodarone and sotalol, inherently target repolarization and carry a significant risk.
Antipsychotics, including haloperidol and ziprasidone, as well as certain antidepressants like citalopram, are frequently implicated in clinical settings.
Healthcare providers utilize validated risk assessment tools before initiating these therapies, often adjusting dosages or selecting alternative agents to minimize the chance of inducing dangerous repolarization abnormalities.
Electrolyte Imbalances and Metabolic Factors
The electrical stability of the heart muscle is critically dependent on a precise extracellular environment, particularly the concentrations of potassium, magnesium, and calcium. Even moderate deviations from the normal range can significantly alter the duration of the QT interval by changing the driving force for ion currents across the cell membrane.
Key Electrolyte Disruptions
Hypokalemia (low potassium levels) is a classic cause, as potassium is the primary determinant of repolarization speed.
Hypomagnesemia (low magnesium levels) independently prolongs the QT interval and can trigger arrhythmias even when potassium levels are normal.
Hypocalcemia (low calcium levels) primarily affects the ST segment but can interact with QT dynamics, while hypercalcemia shortens the interval.
Conditions such as severe malnutrition, eating disorders, or excessive diuretic use can precipitate these imbalances, making electrolyte monitoring a standard component of managing at-risk patients.
